1-5 of 5 results for subject:Streptococcus
Librarians' tools
- Search time
- 0.239 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Streptococcus
- We searched for
- subject_t:Streptococcus OR subject_t:"Strep A" OR subject_t:"Streptococcal infections" OR subject_ses:368447
Primary member
X
Todd, Mark
Type
House
Session
Year
Department
Member
Primary member
More
Todd, Mark (5)
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health (1) what analysis her Department has made of research and experience in other countries of Group B streptococcus screening during pregnancy;
To ask the Secretary of State for Health (1) what analysis her Department has made of research and experience in other countries of Group B streptococcus screening during pregnancy;
Asked by
Mark Todd
(Labour)
Answered by
Liam Byrne
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
15 December 2005
For answer on
19 December 2005
Answered on
17 January 2006
It is for clinicians, in partnership with their patients, to decide on when and how to advise patients of test results. The Royal College of Obstetricians and Gynaecologists' guideline number 36, ““Prevention of Early Onset Neonatal Group B Streptococcal Disease”” and the National Institute for Health and Clinical Excellence's clinical guideline, ““Antenatal Care: Routine care for the healthy pregnant women”” give guidance based on research evidence.The NHS Health Technology Programme has commissioned a study of different approaches to the management of Group B Streptococcus in pregnancy. A review of the international evidence forms part of this work.
Subjects
Pregnancy; Screening; Bacterial diseases; Streptococcus
Date
17 January 2006
Reference
39245; 441 c1298-9W;441 c1298W
House
House of Commons
(2) what guidance is given on when a patient should be advised that Group B streptococcus has been detected in a test.
(2) what guidance is given on when a patient should be advised that Group B streptococcus has been detected in a test.
Asked by
Mark Todd
(Labour)
Answered by
Liam Byrne
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
15 December 2005
For answer on
19 December 2005
Answered on
17 January 2006
It is for clinicians, in partnership with their patients, to decide on when and how to advise patients of test results. The Royal College of Obstetricians and Gynaecologists' guideline number 36, ““Prevention of Early Onset Neonatal Group B Streptococcal Disease”” and the National Institute for Health and Clinical Excellence's clinical guideline, ““Antenatal Care: Routine care for the healthy pregnant women”” give guidance based on research evidence.The NHS Health Technology Programme has commissioned a study of different approaches to the management of Group B Streptococcus in pregnancy. A review of the international evidence forms part of this work.
Subjects
Pregnancy; Screening; Bacterial diseases; Streptococcus
Date
17 January 2006
Reference
39247; 441 c1298-9W;441 c1298W
House
House of Commons
To ask the Secretary of State for Health, what research her Department has conducted into Group B streptococcus testing during pregnancy.
To ask the Secretary of State for Health, what research her Department has conducted into Group B streptococcus testing during pregnancy.
Asked by
Mark Todd
(Labour)
Answered by
Jane Kennedy
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
25 May 2005
For answer on
6 June 2005
Answered on
6 June 2005
The current position is that routine screening of group B streptococcus should not be offered to all pregnant women. The National Institute for Health and Clinical Excellence's guideline on antenatal care states that:
"Pregnant women should not be offered routine antenatal screening for group B streptococcus because evidence of its clinical effectiveness and cost effectiveness remains uncertain".
The United Kingdom national screening committee (NSC) has commissioned an electronic learning resource for health care professionals from the national electronic library for health to promote the Royal College of Obstetricians and Gynaecologists' guideline on prevention of early onset neonatal group B streptococcal disease.
The NSC is also considering further research needs. As part of this, it has asked the health technology assessment programme to undertake two studies:
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost effectiveness and expected value of information analyses.
Prenatal screening for group B streptococcal disease: protocol development for a possible clinical trial.
Subjects
Codes of practice; Pregnancy; Screening; Research; Streptococcus
Date
6 June 2005
Reference
1824; 434 c439-40W;434 c440-1W
House
House of Commons
To ask the Secretary of State for Health, what advice her Department has given to health care professionals on Group B streptococcus testing during pregnancy.
To ask the Secretary of State for Health, what advice her Department has given to health care professionals on Group B streptococcus testing during pregnancy.
Asked by
Mark Todd
(Labour)
Answered by
Jane Kennedy
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
25 May 2005
For answer on
6 June 2005
Answered on
6 June 2005
The current position is that routine screening of group B streptococcus should not be offered to all pregnant women. The National Institute for Health and Clinical Excellence's guideline on antenatal care states that:
"Pregnant women should not be offered routine antenatal screening for group B streptococcus because evidence of its clinical effectiveness and cost effectiveness remains uncertain".
The United Kingdom national screening committee (NSC) has commissioned an electronic learning resource for health care professionals from the national electronic library for health to promote the Royal College of Obstetricians and Gynaecologists' guideline on prevention of early onset neonatal group B streptococcal disease.
The NSC is also considering further research needs. As part of this, it has asked the health technology assessment programme to undertake two studies:
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost effectiveness and expected value of information analyses.
Prenatal screening for group B streptococcal disease: protocol development for a possible clinical trial.
Subjects
Codes of practice; Pregnancy; Screening; Research; Streptococcus
Date
6 June 2005
Reference
1823; 434 c439-40W;434 c440-1W
House
House of Commons
To ask the Secretary of State for Health, if she will make it her policy to provide Group B streptococcus testing on the NHS near the end of pregnancy; and if she will make a statement.
To ask the Secretary of State for Health, if she will make it her policy to provide Group B streptococcus testing on the NHS near the end of pregnancy; and if she will make a statement.
Asked by
Mark Todd
(Labour)
Answered by
Jane Kennedy
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
25 May 2005
For answer on
6 June 2005
Answered on
6 June 2005
The current position is that routine screening of group B streptococcus should not be offered to all pregnant women. The National Institute for Health and Clinical Excellence's guideline on antenatal care states that:
"Pregnant women should not be offered routine antenatal screening for group B streptococcus because evidence of its clinical effectiveness and cost effectiveness remains uncertain".
The United Kingdom national screening committee (NSC) has commissioned an electronic learning resource for health care professionals from the national electronic library for health to promote the Royal College of Obstetricians and Gynaecologists' guideline on prevention of early onset neonatal group B streptococcal disease.
The NSC is also considering further research needs. As part of this, it has asked the health technology assessment programme to undertake two studies:
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost effectiveness and expected value of information analyses.
Prenatal screening for group B streptococcal disease: protocol development for a possible clinical trial.
Subjects
Codes of practice; Pregnancy; Screening; Research; Streptococcus
Date
6 June 2005
Reference
1822; 434 c439-40W;434 c440-1W
House
House of Commons